Literature DB >> 9596665

Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome.

S Levi1, D Girelli, F Perrone, M Pasti, C Beaumont, R Corrocher, A Albertini, P Arosio.   

Abstract

Hereditary hyperferritinemia-cataract syndrome (HHCS) is an autosomal and dominant disease caused by heterogeneous mutations in the iron responsive element (IRE) of the 5' untranslated flanking region of ferritin L-chain mRNA, which reduce the binding to the trans iron regulatory proteins and make L-chain synthesis constitutively upregulated. In the several families identified so far, the serum and tissue L-ferritin levels are fivefold to 20-fold higher than in nonaffected control subjects, iron metabolism is apparently normal, and the only relevant clinical symptom is early onset, bilateral cataract. Some pathogenetic aspects of HHCS remain obscure, with particular reference to the isoferritins produced by HHCS cells, as well as the mechanism of cataract formation. We analyzed lymphoblastoid cell lines obtained from two nonaffected control subjects and from HHCS patients carrying the substitution A40G (Paris-1), G41C (Verona-1), and the deletion of the residues 10-38 (Verona-2) in the IRE structure. Enzyme-linked immunosorbent assays specific for the H- and L-type ferritins showed that L-ferritin levels were up to 20-fold higher in HHCS than in control cells and were not affected by iron supplementation or chelation. Sequential immunoprecipitation experiments of metabolically-labeled cells with specific antibodies indicated that in HHCS cells about half of the L-chain was assembled in L-chain homopolymers, which did not incorporate iron, and the other half was assembled in isoferritins with a high proportion of L-chain. In control cells, all ferritin was assembled in functional heteropolymers with equivalent proportion of H- and L-chains. Cellular and ferritin iron uptake was slightly higher in HHCS than control cells. In addition, we analyzed the lens recovered from cataract surgery of a HHCS patient. We found it to contain about 10-fold more L-ferritin than control lens. The ferritin was fully soluble with a low iron content. It was purified and partially characterized. Our data indicate that: (1) in HHCS cells a large proportion of L-ferritin accumulates as nonfunctional L-chain 24 homopolymers; (2) the concomitant fivefold to 10-fold expansion of ferritin heteropolymers, with a shift to L-chain-rich isoferritins, does not have major effects on cellular iron metabolism; (3) L-chain accumulation occurs also in the lens, where it may induce cataract formation by altering the delicate equilibrium between other water-soluble proteins (ie, crystallins) and/or the antioxidant properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596665

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload.

Authors:  J Kato; K Fujikawa; M Kanda; N Fukuda; K Sasaki; T Takayama; M Kobune; K Takada; R Takimoto; H Hamada; T Ikeda; Y Niitsu
Journal:  Am J Hum Genet       Date:  2001-05-24       Impact factor: 11.025

Review 2.  Recent advance in molecular iron metabolism: translational disorders of ferritin.

Authors:  Junji Kato; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 3.  Iron, the retina and the lens: a focused review.

Authors:  Sixto García-Castiñeiras
Journal:  Exp Eye Res       Date:  2010-03-15       Impact factor: 3.467

Review 4.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

Review 5.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

6.  The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin.

Authors:  A D Mumford; I A Cree; J D Arnold; M C Hagan; K C Rixon; J J Harding
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

7.  Mutant ferritin L-chains that cause neurodegeneration act in a dominant-negative manner to reduce ferritin iron incorporation.

Authors:  Sara Luscieti; Paolo Santambrogio; Béatrice Langlois d'Estaintot; Thierry Granier; Anna Cozzi; Maura Poli; Bernard Gallois; Dario Finazzi; Angela Cattaneo; Sonia Levi; Paolo Arosio
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

8.  Altered ferritin subunit composition: change in iron metabolism in lens epithelial cells and downstream effects on glutathione levels and VEGF secretion.

Authors:  Jill Harned; Jenny Ferrell; Marilyn M Lall; Lloyd N Fleisher; Steven Nagar; Malgorzata Goralska; M Christine McGahan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-09       Impact factor: 4.799

9.  A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload.

Authors:  Caroline Kannengiesser; Anne-Marie Jouanolle; Gilles Hetet; Annick Mosser; Françoise Muzeau; Dominique Henry; Edouard Bardou-Jacquet; Martine Mornet; Pierre Brissot; Yves Deugnier; Bernard Grandchamp; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

10.  Crystallization and preliminary X-ray diffraction data for the aconitase form of human iron-regulatory protein 1.

Authors:  J Dupuy; C Darnault; X Brazzolotto; L C Kühn; J M Moulis; A Volbeda; J C Fontecilla-Camps
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.